Name Confusion Market Research

In today’s world - the stakes are high in the healthcare industry. The domestic and international regulatory agencies are becoming ever more restrictive in the“name evaluation process”.

The Intasol Group team has been globally helping clients from initial creative right through to the regulatory filing process.

Intasol’s healthcare team has vast experience in multiple therapeutic areas as well as medical devices and OTC products. Intasol is equipped to meet the challenges that confront the healthcare industry in today’s global climate. Our process will also help you validate your positioning and strategies.

Intasol’s proprietary name confusion market research will provide a full series of measurements that check for name confusion as well as market realities in today's healthcare marketplace.

Our global, customized research includes the following offerings:

• Name safety/validation research which meets all FDA/EMEA/HC requirements

• Comprehensive real-time product analysis

• Brand equity evaluations

• Trademark confusion analysis

• Segmentation research

• OnPoint™ prescription drug research